Titlebook: Chemotherapy Protocols and Infusion Sequence; Schedule Considerati Iago Dillion Lima Cavalcanti Book 2022 The Editor(s) (if applicable) and

只看該作者 · 發(fā)表于 2025-3-28 20:25:44

Book 2022ence can compromise the patient‘s treatment, this work will provide support to professionals working in the field of oncology in assessing each chemotherapy infusion sequence. The introductory chapters present the definition, indication, and the risks and benefits of polypharmacy in cancer therapy,

只看該作者 · 發(fā)表于 2025-3-29 00:30:04

Combined Therapy for the Treatment of Cancer,d be taken into account when choosing the best combination for the treatment of a particular cancer. Finally, I discuss the toxicity profiles of the treatment of various cancers, such as toxicity related to the treatment of breast, lung, colorectal, prostate, cervix, and head and neck cancers.

只看該作者 · 發(fā)表于 2025-3-29 03:25:34

只看該作者 · 發(fā)表于 2025-3-29 07:34:12

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經(jīng)驗總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 04:49
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved